REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND CLINICAL OUTCOMES OF PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (ES-SCLC) IN ALBERTA, CANADA

被引：0
|
作者：
Suri, G. [1 ]
Boyne, D. J. [2 ]
Caveen, M. [3 ]
Mak, D. [3 ]
Takundwa, R. [4 ]
Wani, R. J. [3 ]
Cheung, W. [2 ]
机构：
[1] Amgen Ltd, Uxbridge, England
[2] Oncol Outcomes, Calgary, AB, Canada
[3] Amgen Canada Inc, Mississauga, ON, Canada
[4] Amgen Ltd, Uxbridge, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO37
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND HEALTHCARE COSTS (HCC) OF PATIENTS WITH SMALL-CELL LUNG CANCER (SCLC) IN THE US
    Suri, G.
    Aslam, S.
    Takundwa, R.
    Giannopoulou, M.
    VALUE IN HEALTH, 2024, 27 (06) : S149 - S149
  • [2] Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada
    O'Sullivan, Dylan E.
    Cheung, Winson Y.
    Syed, Iqra A.
    Moldaver, Daniel
    Shanahan, Mary Kate
    Bebb, D. Gwyn
    Sit, Christina
    Brenner, Darren R.
    Boyne, Devon J.
    CURRENT ONCOLOGY, 2021, 28 (04) : 3091 - 3103
  • [3] Real-world treatment patterns, clinical outcomes, and health care resource utilization in extensive-stage small cell lung cancer in Canada.
    O'Sullivan, Dylan E.
    Brenner, Darren
    Syed, Iqra
    Shanahan, Mary Kate
    Moldaver, Daniel
    Sit, Christina
    Bebb, D. Gwyn
    Cheung, Winson Y.
    Boyne, Devon J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting?
    Elijah, Joseph
    Jain, Prantesh
    Holdsworth, Allison
    Baron, Jeffrey
    Przespolewski, Eugene
    Wang, Katy
    Attwood, Kristopher
    Billias, Christina
    Dy, Grace K.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (09)
  • [5] Treatment patterns and outcomes of immunotherapy in extensive-stage small-cell lung cancer based on real-world practice
    Yang, Yaning
    Ai, Xin
    Xu, Haiyan
    Yang, Guangjian
    Yang, Lu
    Hao, Xuezhi
    Yang, Ke
    Mi, Yuling
    Wang, Guizhen
    Zhang, Shuyang
    Lei, Siyu
    Wang, Yan
    THORACIC CANCER, 2022, 13 (23) : 3295 - 3303
  • [6] Anlotinib combined with chemotherapy in the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC): A real-world study
    Gao, F.
    Zhao, Y.
    Li, X.
    Li, Y.
    Ma, T.
    Li, Q.
    Tang, X.
    Han, X.
    Yi, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1069 - S1069
  • [7] Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
    Xiang, Y.
    Tang, Y.
    Luan, T.
    Mengchen, L.
    Shi, W.
    Chin, A. G. W.
    Feng, X.
    Wang, F.
    Sun, X. W.
    Bao, Z.
    Zhou, J.
    Zhao, J.
    Wu, H.
    Fu, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S1666 - S1667
  • [8] Real-world (rw) outcomes to chemoimmunotherapy and biomarker analysis in extensive-stage small cell lung cancer (ES SCLC)
    Panagiotou, E.
    Livanou, M. E.
    Montgomery, A.
    Mastrogeorgiou, M.
    Moeckel, C.
    Syrigos, N.
    Mouratidis, I.
    Charpidou, A.
    Georgakopoulos-Soares, I.
    Vathiotis, I.
    ANNALS OF ONCOLOGY, 2023, 34 : S1069 - S1069
  • [9] Real-World Outcomes of Platinum-immunotherapy as First-Line (1L) Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Ganti, A. K.
    Prince, T.
    Back, S.
    Chansakul, A.
    Boccuti, A.
    Rengarajan, B.
    Chakrabarti, D.
    Li, W.
    Fan, L.
    Cao, Y.
    D'Agostino, R., Jr.
    Fan, X.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S664 - S665
  • [10] Patterns of Disease Progression after Carboplatin/Etoposide plus Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
    Higgins, K. A.
    Curran, W. J., Jr.
    Liu, S. V.
    Yu, W.
    Brockman, M.
    Johnson, A.
    Bara, I.
    Bradley, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (05): : 1398 - 1398
12345